Is E-cadherin a useful surrogate marker to predict chemosensitivity of chemotherapy for triple-negative breast cancer?

被引：1
|
作者：
Kashiwagi, S. [1 ]
Yashiro, M. [1 ]
Takashima, T. [1 ]
Aomatsu, N. [1 ]
Kawajiri, H. [1 ]
Onoda, N. [1 ]
Nakata, B. [1 ]
Ishikawa, T. [1 ]
Hirakawa, K. [1 ]
机构：
[1] Osaka City Univ, Dept Surg Oncol, Grad Sch Med, Osaka 558, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.1077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] E-cadherin is a useful surrogate maker to predict chemosensitivity of neoadjuvant chemotherapy for breast cancer
    Aomatsu, Naoki
    Yashiro, Masakazu
    Kashiwagi, Shinichiro
    Takashima, Tsutomu
    Kawajiri, Hidemi
    Onoda, Naoyoshi
    Ishikawa, Tetsuro
    Hirakawa, Kosei
    CANCER RESEARCH, 2011, 71
  • [2] E-cadherin expression might be a predictive marker for chemosensitivity in triple-negative breast cancer
    Shinichiro, Kashiwagi
    Yashiro, Masakazu
    Takashima, Tsutomu
    Noda, Satoru
    Kawajiri, Hidemi
    Matsuoka, Junko
    Fuyuhiro, Yuhiko
    Kato, Yukihiro
    Doi, Yosuke
    Kubo, Naoshi
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Inoue, Toru
    Sawada, Tetsuji
    Onoda, Naoyoshi
    Nakata, Bunzo
    Ohira, Masaichi
    Ishikawa, Tetsuro
    Hirakawa, Kosei
    CANCER RESEARCH, 2010, 70
  • [3] The Predictive Role of E-cadherin and Androgen Receptor on In Vitro Chemosensitivity in Triple-negative Breast Cancer
    Koo, Ja Seung
    Jung, Woohee
    Jeong, Joon
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (09) : 560 - 568
  • [4] Significance of E-cadherin expression in triple-negative breast cancer
    S Kashiwagi
    M Yashiro
    T Takashima
    S Nomura
    S Noda
    H Kawajiri
    T Ishikawa
    K Wakasa
    K Hirakawa
    British Journal of Cancer, 2010, 103 : 249 - 255
  • [5] Significance of E-cadherin expression in triple-negative breast cancer
    Kashiwagi, S.
    Yashiro, M.
    Takashima, T.
    Nomura, S.
    Noda, S.
    Kawajiri, H.
    Ishikawa, T.
    Wakasa, K.
    Hirakawa, K.
    BRITISH JOURNAL OF CANCER, 2010, 103 (02) : 249 - 255
  • [6] CD133 is a useful surrogate marker to predict chemosensitivity of neoadjuvant chemotherapy for breast cancer
    Aomatsu, Naoki
    Yashiro, Masakazu
    Kashiwagi, Shinichiro
    Morisaki, Tamami
    Fukuoka, Tatsunari
    Hirakawa, Tosiki
    Hasegawa, Tsuyoshi
    Matsuoka, Junko
    Takashima, Tsutomu
    Kawajiri, Hidemi
    Onoda, Naoyoshi
    Ishikawal, Tetsuro
    Hirakawa, Kosei
    CANCER RESEARCH, 2012, 72
  • [7] The Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer (TNBC)
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 72A - 72A
  • [8] The Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer (TNBC)
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 72A
  • [9] Prognostic Value of E-Cadherin and β-Cagengn tin Triple-Negative Breast Cancer
    Shen, Tiansheng
    Zhang, Kui
    Siegal, Gene P.
    Wei, Shi
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (05) : 603 - 610
  • [10] The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer
    Dabei Tang
    Shanqi Xu
    Qingyuan Zhang
    Wenhui Zhao
    Medical Oncology, 2012, 29 : 526 - 533
12345